Validation of Plasma Clearance of 51Cr-EDTA in Adult Renal Transplant Recipients: Comparison with Inulin Renal Clearance
Overview
Authors
Affiliations
Plasma clearance of (51)Cr-EDTA ((51)Cr-EDTA-Cl) is an alternative method to evaluate glomerular filtration rate (GFR). This study aimed to investigate the concordance between (51)Cr-EDTA-Cl and renal inulin clearance (In-Cl) in renal transplant recipients as well to determine the repeatability of (51)Cr-EDTA-Cl in kidney donors. Forty four kidney recipients and 22 kidney donors were enrolled. Simultaneous measurements of (51)Cr-EDTA-Cl and In-Cl were performed. A single dose of 3.7MBq of (51)Cr-EDTA was injected and the plasma disappearance curve was created by taking blood samples at 2, 4, 6 and 8 h after injection. Bland and Altman statistical approach was used to quantify the agreement between In-Cl and (51)Cr-EDTA-Cl and to determine the better concordance between all possibilities of measure for the (51)Cr-EDTA-Cl. The mean of In-Cl was 44.5 +/- 17.9 ml/min/1.73 m(2). There was a positive correlation between In-Cl and all possible measurements of (51)Cr-EDTA-Cl. (51)Cr-EDTA-Cl with two samples taken at 4 and 8 h or at 4 and 6 h presenting the narrow limits of agreement and a difference (bias) of 2.8 and 2.7 ml/min, respectively. Two plasma sampling for (51)Cr-EDTA-Cl was a reliable method to measure GFR compared with In-Cl and comprises a suitable method to be used in kidney transplanted patients.
Scarsi E, Dorighi U, Adriano E, Grandis M, Balestrino M J Clin Med. 2024; 13(23).
PMID: 39685653 PMC: 11642150. DOI: 10.3390/jcm13237194.
Gomes A, Coura Filho G, Gil Junior L, Caires R, Burdmann E, Buchpiguel C Clinics (Sao Paulo). 2024; 79:100427.
PMID: 38945113 PMC: 11261263. DOI: 10.1016/j.clinsp.2024.100427.
Post Liver Transplant Renal Dysfunction-Evaluation, Management and Immunosuppressive Practice.
Raja K, Panackel C J Clin Exp Hepatol. 2024; 14(2):101306.
PMID: 38274509 PMC: 10806298. DOI: 10.1016/j.jceh.2023.101306.
Raynaud M, Al-Awadhi S, Juric I, Divard G, Lombardi Y, Basic-Jukic N BMJ. 2023; 381:e073654.
PMID: 37257905 PMC: 10231444. DOI: 10.1136/bmj-2022-073654.
Balouzet C, Michon-Colin A, Dupont L, Vidal-Petiot E, Prot-Bertoye C, Baron S J Nephrol. 2023; 36(9):2457-2465.
PMID: 37093492 DOI: 10.1007/s40620-023-01612-0.